Beth Israel Deaconess Medical Center

What are the most promising lifestyle and tech options to harness lifelong neuroplasticity?

by

What are the most promis­ing lifestyle and tech options to har­ness life­long neu­ro­plas­tic­i­ty, and what are key road­blocks ahead? (record­ing requires reg­is­tra­tion; view slid­edeck above or Here)

  • Dr. Álvaro Pas­cual-Leone, Direc­tor of the Beren­son-Allen Cen­ter for Non­in­va­sive Brain Stim­u­la­tion at Beth Israel Dea­coness Med­ical Center
  • Dr. David Bartrés-Faz, Prin­ci­pal Inves­ti­ga­tor of the Barcelona Brain Health Ini­tia­tive (BBHI)
  • Dr. Simone Schurle, Assis­tant Pro­fes­sor for Respon­sive Bio­med­ical Sys­tems at the Swiss Fed­er­al Insti­tute of Technology
  • Chaired by: Dr. David Bach, Founder and Pres­i­dent of the Platy­pus Institute

Slid­edeck above sup­port­ed ses­sion held dur­ing the 2017 Sharp­Brains Vir­tu­al Sum­mit: Brain Health & Enhance­ment in the Dig­i­tal Age (Decem­ber 5–7th).

Dr. Tom Insel and 12 other world-class brain experts confirmed to Speak @ 2017 SharpBrains Virtual Summit (December 5–7th, 2017)

by

_______

We are proud to share what’s already shap­ing up to be a quite spec­tac­u­lar and unique Speak­ing Ros­ter at the 2017 Sharp­Brains Vir­tu­al Sum­mit, start­ing with Thomas R. lnsel, MD, a psy­chi­a­trist, neu­ro­sci­en­tist, and cur­rent­ly a co-founder and Pres­i­dent of Mind­strong Health. From 2002–2015, Dr. Insel served as Direc­tor of the Nation­al Insti­tute of Men­tal Health (NIMH), [Read more…] about Dr. Tom Insel and 12 oth­er world-class brain experts con­firmed to Speak @ 2017 Sharp­Brains Vir­tu­al Sum­mit (Decem­ber 5–7th, 2017)

Trend: Biopharma embraces digital cognitive assessments to identify behavioral health biomarkers

by

_______

The hunt for behav­ioral health bio­mark­ers is har­ness­ing dig­i­tal health at the research stage (Med­C­i­ty News):

“Dig­i­tal health com­pa­nies are going through an inter­est­ing trans­for­ma­tion as research insti­tu­tions real­ize the ben­e­fit of their tech­nol­o­gy to col­lect and man­age data for a host of stud­ies. The bio­phar­ma industry’s embrace of some dig­i­tal health tools to man­age the costs of drug devel­op­ment has led to more fre­quent col­lab­o­ra­tions with [Read more…] about Trend: Bio­phar­ma embraces dig­i­tal cog­ni­tive assess­ments to iden­ti­fy behav­ioral health biomarkers

Research: Could studying the placebo effect change the way we think about medicine?

by

The Pow­er of Noth­ing: Could study­ing the place­bo effect change the way we think about med­i­cine? (The New Yorker):

“For years, Ted Kaptchuk per­formed acupunc­ture at a tiny clin­ic in Cam­bridge, a few miles from his cur­rent office, at the Har­vard Med­ical School. He opened for busi­ness in 1976, hav­ing just returned from Asia, where he had spent four years hon­ing his craft. Not long after he arrived in Boston, he treat­ed an Armen­ian woman for chron­ic bron­chi­tis. A few weeks lat­er, the woman returned with her hus­band and told Kaptchuk that he had “cured” her.” [Read more…] about Research: Could study­ing the place­bo effect change the way we think about medicine?